NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
This upcoming NIH and CDC grant will invite eligible US small businesses to apply for SBIR funding for innovative research requiring clinical trials, pending program reauthorization.
Funder: National Institutes of Health
Due Dates: April 5, 2029
Funding Amounts: Not specified; award size varies by project, and cost sharing/matching is required.
Summary: Provides follow-on funding for U.S. small businesses with prior NIH SBIR/STTR Phase II awards to support late-stage R&D and commercialization.
Key Information: Only one Phase IIB Strategic Breakthrough award allowed per project; applicants must apply within six due dates after their Phase II budget period ends.
Description
This opportunity offers additional support to U.S. small businesses that have previously received an NIH SBIR or STTR Phase II award. The Phase IIB Strategic Breakthrough Award aims to bridge the funding gap between the end of Phase II and the commercialization of innovative health-related technologies. The award supports later-stage research and development activities, helping projects progress toward market readiness and public health impact.
